06Jan/14

UK's NICE Issues Final Appraisal Determination on CTI Lymphoma Drug – Drug Discovery & Development

January 6, 2014Monoclonal Anti-CD20 Antibodiesadmin

UK’s NICE Issues Final Appraisal Determination on CTI Lymphoma Drug
Drug Discovery & Development
… reviewed CTI’s updated data analysis showing Pixuvri’s cost effectiveness and recommended the treatment as an option for certain people with histologically confirmed aggressive B-cell NHL who have previously received rituximab and are receiving …
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from …MarketWatch

all 10 news articles »

06Jan/14

New Method Transports Antibodies Across the Blood-Brain Barrier – Pharmaceutical Technology Magazine

January 6, 2014Antibodiesadmin

New Method Transports Antibodies Across the Blood-Brain BarrierPharmaceutical Technology MagazineA study has demonstrated that the Roche-designed Brain Shuttle technology efficiently transfers investigational antibodies from the blood through the blood…

06Jan/14

Two bone marrow transplant and five months in isolation – let's hope 2014 is a … – Sunderland Echo

January 6, 2014Polyclonal Anti-T-Cell Antibodiesadmin

Sunderland Echo

Two bone marrow transplant and five months in isolation – let’s hope 2014 is a …
Sunderland Echo
After overcoming the potentially fatal condition, Bryant, of Hylton Castle, suffered bone marrow failure in January, and was given anti-thymocyte globulin (ATG) treatment, which uses horse or rabbit antibodies, to try to fight the condition. But when …

06Jan/14

Research and Markets: Global Monoclonal Antibodies Pipeline Analysis – 4-traders (press release)

January 6, 2014Antibodiesadmin

Research and Markets: Global Monoclonal Antibodies Pipeline Analysis4-traders (press release)The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal a…

06Jan/14

Research and Markets: Global Monoclonal Antibodies Pipeline Analysis – Business Wire (press release)

January 6, 2014Antibodiesadmin

Research and Markets: Global Monoclonal Antibodies Pipeline AnalysisBusiness Wire (press release)The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclon…

06Jan/14

New Market Report Now Available: Monoclonal Antibodies Market in Colorectal … – SBWire (press release)

January 6, 2014Antibodiesadmin

New Market Report Now Available: Monoclonal Antibodies Market in Colorectal …
SBWire (press release)
GBI Research, has released the pharma report “Monoclonal Antibodies Market in Colorectal Cancer to 2019 – Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth”. There are currently three monoclonal …

06Jan/14

NICE issues Final Appraisal Determination for PIXUVRI (pixantrone) drug – News-Medical.net

January 6, 2014Monoclonal Anti-CD20 Antibodiesadmin

NICE issues Final Appraisal Determination for PIXUVRI (pixantrone) drug
News-Medical.net
… showing PIXUVRI’s cost effectiveness and recommended the treatment as an option for certain people with histologically confirmed aggressive B-cell NHL who have previously received rituximab and are receiving PIXUVRI as a third- or fourth-line …
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from …Sacramento Bee

all 5 news articles »

03Jan/14

Future of dermatologic innovation has bright spots – ModernMedicine

January 3, 2014Monoclonal Anti-CD20 Antibodiesadmin

Future of dermatologic innovation has bright spots
ModernMedicine
“We’re seeing the use of biologic agents, like rituximab used to treat lymphomas, now being used to treat inflammatory blistering diseases, such as pemphigus vulgaris. We’re also seeing pathway inhibitors and immune checkpoint modulators in the …

03Jan/14

Research and Markets: High Level of Competition between Emerging and … – 4-traders (press release)

January 3, 2014Monoclonal Anti-CD20 Antibodiesadmin

Research and Markets: High Level of Competition between Emerging and …4-traders (press release)The RA market contains several of the most profitable therapies across the entire drug industry. Humira (adalimumab), Rituxan (rituximab) Remicade (inflixi…

02Jan/14

Medtronic, Inc. : Patent Issued for Humanized Anti-Amyloid Beta Antibodies – 4-traders (press release)

January 2, 2014Antibodiesadmin

Medtronic, Inc. : Patent Issued for Humanized Anti-Amyloid Beta Antibodies4-traders (press release)By a News Reporter-Staff News Editor at Life Science Weekly — Medtronic, Inc. ( Minneapolis, MN ) has been issued patent number 8614298, according to ne…

Category Archives: Antibodies